ENCell
ENCell is a biotech company in Seoul, South Korea, founded in 2018. It has raised $43.4M across 3 rounds, most recently a $17.5M Growth Equity in June 2022.
Leading in Cell and Gene Therapy CDMO
- Headquarters
- Seoul
- Founded
- 2018
- Business Model
- B2B
- Website
- encellinc.com
- Total Funding
- $43.4M
- Last Round
- $17.5M Growth EquityJun 2022
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.
About
ENCELL Co., Ltd. is a KOSDAQ-listed cell and gene therapy company that offers contract development and manufacturing (CDMO) and contract quality testing (CQT) through globally recognized GMP facilities. Its ROCKET platform provides multi-product GMP production, while its research pipeline includes next-generation stem cell therapies, cancer immunotherapy cell treatments, and AAV-based gene therapies. ENCELL also develops its own therapeutics and works as a manufacturing partner that helps clients execute product development under a rigorous quality-assurance system.
Summary
It has raised $43.4M in total across 3 rounds, most recently a $17.5M Growth Equity round in Jun 2022. Investors include Samsung Venture Investment Corporation, Smilegate Investment and AJU IB Investment.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2022
Sign up to see all 3 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/encell"><img src="https://indexed.vc/api/badge/company/encell" alt="ENCell on Indexed.vc" width="260" height="76" /></a>